A Whole Blood Assay for AR-V7 and AR(v567es) in Prostate Cancer Patients

PURPOSE: The majority of prostate cancer mortality can be attributed to metastatic castration-resistant prostate cancer, an advanced stage which remains incurable despite recent advances. The androgen receptor (AR) signaling axis remains active in CRPC. Recent studies suggest that the expression of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Urol
Autors principals: Liu, Xichun, Ledet, Elisa, Li, Dongying, Dotiwala, Ary, Steinberger, Allie, Feibus, Allison, Li, Jianzhuo, Qi, Yanfeng, Silberstein, Jonathan, Lee, Benjamin, Dong, Yan, Sartor, Oliver, Zhang, Haitao
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161406/
https://ncbi.nlm.nih.gov/pubmed/27449259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2016.06.095
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars